APA

Tafuri A., De Felice L., Petrucci M. T., Mascolo M. G., Ricciardi M. R., Ciliberti C., Martelli M. P. & Petti M. C. (19971208). Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen. : Cytokines and molecular therapy.

Chicago

Tafuri A, De Felice L, Petrucci M T, Mascolo M G, Ricciardi M R, Ciliberti C, Martelli M P and Petti M C. 19971208. Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen. : Cytokines and molecular therapy.

Harvard

Tafuri A., De Felice L., Petrucci M. T., Mascolo M. G., Ricciardi M. R., Ciliberti C., Martelli M. P. and Petti M. C. (19971208). Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen. : Cytokines and molecular therapy.

MLA

Tafuri A, De Felice L, Petrucci M T, Mascolo M G, Ricciardi M R, Ciliberti C, Martelli M P and Petti M C. Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen. : Cytokines and molecular therapy. 19971208.